[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

RNA Analysis Market

October 2021 | 55 pages | ID: R18E522DF3C5EN
BCC Research

US$ 1,975.00 US$ 3,950.00 -50 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Scope:

This study offers a global view of the RNA analysis for various applications. This report analyzes and assesses different types of RNA analysis involved, namely microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing. It also provides information by application, categorized as clinical diagnosis, drug discovery and toxicogenomics.

BCC Research analyzed and made projections for each market and its type, new products and technological advances. Also included in the report are a discussion of the impact of COVID-19 on the market and profiles of leading companies in the RNA analysis market. The leading firms in the market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories, CD Genomics, Promega Corp., Illumina Inc., Qiagen NV, Danaher Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, Fluidigm Corp., and Eurofins Scientific.

By region, this report is broken down into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA).

Report Includes:
  • 41 tables
  • An overview of the global RNA analysis/transcriptomics market
  • Analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Detailed analysis of the current market trends and forecast, relevant R&D activities, new products launches and product enhancement in the industry and discussion of regulatory elements that are affecting the future marketplace
  • Detailed description of RNA analysis types such as microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAI gene silencing, and coverage of their industry structure
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players in the market including Agilent Technologies Inc., Bio-Rad Laboratories Inc., CD Genomics, Danaher, Roche, Illumina Inc., Merck KGAA, Qiagen, Thermo Fisher Scientific Inc.
CHAPTER 1 INTRODUCTION

Scope of the Report
Reasons for Doing This Study
Information Sources
Research Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

CHAPTER 3 OVERVIEW

Impact of COVID-19 on the Market for RNA Analysis/Transcriptomics

CHAPTER 4 GLOBAL MARKET FOR RNA ANALYSIS/TRANSCRIPTOMICS

Global Market for RNA Analysis/Transcriptomics
Global Market for RNA Analysis/Transcriptomics by Technology
Polymerase Chain Reaction
Sequencing Technologies
Microarrays
RNAi Gene Silencing
Global Market for RNA Analysis/Transcriptomics by Application
Drug Discovery
Toxicogenomics
Clinical Diagnosis
Global Market for RNA Analysis/Transcriptomics by Region
North America
Europe
Asia-Pacific
South America
Middle East and Africa

CHAPTER 5 DRIVERS AND CHALLENGES

Market Drivers
Growing Research in Transcriptomics
Increasing Research in Medicinal Plant Transcriptomics
Market Challenges
Working with Huge Volumes of Data

CHAPTER 6 SUPPLIER LANDSCAPE, COMPANY SHARE ANALYSIS AND COMPANY PROFILES

Mergers and Acquisitions
Company Share Analysis
Company Profiles
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
CD GENOMICS
DANAHER CORP.
EUROFINS SCIENTIFIC
F. HOFFMANN-LA ROCHE LTD.
FLUIDIGM CORP.
ILLUMINA INC.
MERCK KGAA
PROMEGA CORP.
QIAGEN NV
THERMO FISHER SCIENTIFIC INC.

LIST OF TABLES

Summary Table: Global Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 1: Global Market for RNA Analysis/Transcriptomics, Through 2026
Table 2: Global Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 3: Global Market for Polymerase Chain Reaction, Through 2026
Table 4: Global Market for Sequencing Technologies, Through 2026
Table 5: Global Market for Microarrays, Through 2026
Table 6: Global Market for RNAi Gene Silencing, Through 2026
Table 7: Global Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 8: Global Market for RNA Analysis in Drug Discovery, Through 2026
Table 9: Global Market for RNA Analysis in Toxicogenomics, Through 2026
Table 10: Global Market for RNA Analysis in Clinical Diagnostics, Through 2026
Table 11: Global Market for RNA Analysis/Transcriptomics, by Region, Through 2026
Table 12: North American Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 13: North American Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 14: European Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 15: European Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 16: Asia-Pacific Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 17: Asia-Pacific Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 18: South American Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 19: South American Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 20: Middle East and African Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 21: Middle East and African Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 22: Agilent Technologies Inc.: Products
Table 23: Agilent Technologies Inc.: Financial Performance, 2017–2020
Table 24: Bio-Rad Laboratories Inc.: Products
Table 25: Bio-Rad Laboratories Inc.: Financial Performance, 2017–2020
Table 26: CD Genomics: Products
Table 27: Danaher Corp.: Financial Performance, 2018–2020
Table 28: Eurofins Scientific: Products
Table 29: Eurofins Scientific: Financial Performance, 2019 and 2020
Table 30: Roche: Products
Table 31: Roche: Financial Performance, 2019 and 2020
Table 32: Fluidigm Corp.: Products
Table 33: Fluidigm Corp.: Financial Performance, 2018–2020
Table 34: Illumina Inc.: Products and Services
Table 35: Illumina Inc.: Financial Performance, 2018–2020
Table 36: Merck KGaA: Financial Performance, 2019 and 2020
Table 37: Promega Corp: Solutions
Table 38: Qiagen NV: Products
Table 39: Qiagen NV: Financial Performance, 2017–2020
Table 40: Thermo Fisher Scientific Inc.: Products
Table 41: Thermo Fisher Scientific Inc.: Financial Performance, 2017–2020

LIST OF FIGURES

Summary Figure: Global Market for RNA Analysis/Transcriptomics, by Technology, 2019–2026
Figure 1: Global Market for RNA Analysis/Transcriptomics, 2019–2026
Figure 2: Global Market for Polymerase Chain Reaction, 2019–2026
Figure 3: Global Market for Sequencing Technologies, 2020–2026
Figure 4: Global Market for Microarrays, 2019–2026
Figure 5: Global Market for RNAi Gene Silencing, 2019–2026
Figure 6: Global Market for RNA Analysis in Drug Discovery, 2020–2026
Figure 7: Global Market for RNA Analysis in Toxicogenomics, 2019-2026
Figure 8: Global Market for RNA Analysis in Clinical Diagnostics, 2019–2026
Figure 9: Global Market Shares of RNA Analysis/Transcriptomics, by Region, 2020
Figure 10: Global Market Revenue Shares of RNA Analysis/Transcriptomics, by Company, 2020


More Publications